Article
Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study.
Annals of nuclear medicine - 1 Aug 2024
Lue Kun-Han, Chen Yu-Hung, Chu Sung-Chao, Lin Chih-Bin, Wang Tso-Fu, Liu Shu-Hsin
Abstract excerpt
OBJECTIVE: To investigate the prognostic value of 18F-FDG PET-based intensity, volumetric features, and deep learning (DL) across different generations of PET scanners in patients with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma receiving tyrosine kinase inhibitor (TKI) treatment. METHODS: We retrospectively analyzed the pre-treatment 18F-FDG PET of 217 patients with advanced-stage lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
